Roche AGs US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer.
Tag Archive for: Roche
Schwan follows Franz, Schinecker follows Schwan.
Roche AGs US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer.
Schwan follows Franz, Schinecker follows Schwan.